On Friday, May 15th, Health Canada officially granted Motif Labs Ltd a Standard Processing license under the Cannabis Act after an extensive 2-year application and vetting process. The company will operate as a contract manufacturing hub, partnering with cannabis and hemp cultivators, as well as 3rd party brands, to create a range of concentrate-based products. Motif is currently seeing significant demand for bulk oils and vaporizers, and has significant in-house capabilities to fulfill this market need.
As an essential business, the company has spent extensive time designing a robust COVID-19 operation plan to ensure it can successfully launch in a safe and effective manner.
In addition to the growing medicinal and recreational cannabis markets, Motif’s products (high purity, bulk cannabinoid oils) are in high demand in a number of other industries including pharmaceutical, health and beauty, beverage, food processing and pet care. Within its Phase one footprint of 12,500 sqft, Motif will be capable of processing more than 200,000kg of biomass annually.
The company currently has 11 FTE’s and is actively hiring a number of additional positions. By the end of 2020, Motif expects to employ 30-40 individuals at its site. With active R&D capabilities, the company plans to quickly expand into other product categories including water soluble oils and cannabinoid isolates (99% purity).